A recent study by Küçükköse and colleagues (51) also highlighted the importance of proliferating cytotoxic T cells in MMR-deficient colorectal cancers, showing that nonmetastatic tumors had higher levels of these cells than metastatic tumors. This evidence concerns the gene MRC1 and colorectal cancer.